BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 37564215)

  • 1. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases.
    Feng Q; Yang Y; Ren K; Qiao Y; Sun Z; Pan S; Liu F; Liu Y; Huo J; Liu D; Liu Z
    Int J Biol Sci; 2023; 19(12):3726-3743. PubMed ID: 37564215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials.
    Feng Q; Yu X; Qiao Y; Pan S; Wang R; Zheng B; Wang H; Ren KD; Liu H; Yang Y
    Front Pharmacol; 2022; 13():858676. PubMed ID: 35517803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities.
    Wang H; Liu D; Zheng B; Yang Y; Qiao Y; Li S; Pan S; Liu Y; Feng Q; Liu Z
    Int J Biol Sci; 2023; 19(9):2678-2694. PubMed ID: 37324941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ferroptosis in acute kidney injury.
    Ni L; Yuan C; Wu X
    Cell Death Dis; 2022 Feb; 13(2):182. PubMed ID: 35210424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ferroptosis in the development of acute and chronic kidney diseases.
    Zhou Y; Zhang J; Guan Q; Tao X; Wang J; Li W
    J Cell Physiol; 2022 Dec; 237(12):4412-4427. PubMed ID: 36260516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.
    Zhang X; Li X
    Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Role of Ferroptosis in Acute Kidney Injury.
    Hu Z; Zhang H; Yang SK; Wu X; He D; Cao K; Zhang W
    Oxid Med Cell Longev; 2019; 2019():8010614. PubMed ID: 31781351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Insight into Ferroptosis in Kidney Diseases.
    Yang L; Liu Y; Zhou S; Feng Q; Lu Y; Liu D; Liu Z
    Am J Nephrol; 2023; 54(5-6):184-199. PubMed ID: 37231767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress on ferroptosis in diabetic kidney disease.
    Wu Y; Chen Y
    Front Endocrinol (Lausanne); 2022; 13():945976. PubMed ID: 36246888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases.
    Li J; Zheng S; Fan Y; Tan K
    Cell Death Dis; 2023 Sep; 14(9):628. PubMed ID: 37739961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury.
    Hosohata K; Harnsirikarn T; Chokesuwattanaskul S
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis in renal fibrosis: a mini-review.
    Yang SQ; Zhao X; Zhang J; Liao DY; Wang YH; Wang YG
    J Drug Target; 2024 May; ():1-9. PubMed ID: 38721679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy.
    Li J; Li L; Zhang Z; Chen P; Shu H; Yang C; Chu Y; Liu J
    Front Immunol; 2023; 14():1294317. PubMed ID: 38111578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment.
    Qiao O; Wang X; Wang Y; Li N; Gong Y
    J Adv Res; 2023 Dec; 54():211-222. PubMed ID: 36702249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis.
    Jiayi H; Ziyuan T; Tianhua X; Mingyu Z; Yutong M; Jingyu W; Hongli Z; Li S
    Pharmacol Res; 2024 Apr; 202():107139. PubMed ID: 38484857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury.
    Shi Y; Shi X; Zhao M; Chang M; Ma S; Zhang Y
    Biomed Pharmacother; 2023 Jul; 163():114849. PubMed ID: 37172334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis: past, present and future.
    Li J; Cao F; Yin HL; Huang ZJ; Lin ZT; Mao N; Sun B; Wang G
    Cell Death Dis; 2020 Feb; 11(2):88. PubMed ID: 32015325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 3-hydroxypyridin-4(1H)-One derivatives as ferroptosis inhibitors with iron-chelating and reactive oxygen species scavenging activities and therapeutic effect in cisplatin-induced cytotoxicity.
    Zhang C; Lu Y; Zhang J; Zang A; Ren J; Zheng Z; Fan M; Xie Y
    Eur J Med Chem; 2024 Jan; 263():115945. PubMed ID: 37976709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway.
    Lu Q; Yang L; Xiao JJ; Liu Q; Ni L; Hu JW; Yu H; Wu X; Zhang BF
    Free Radic Biol Med; 2023 Feb; 195():89-102. PubMed ID: 36581059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
    Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.